Vitamin D-3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C

被引:0
|
作者
Schmitz, JP
Schwartz, Z
Sylvia, VL
Dean, DD
Calderon, F
Boyan, BD
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT ORTHOPAED, SAN ANTONIO, TX 78284 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT ORAL & MAXILLOFACIAL SURG, SAN ANTONIO, TX 78284 USA
[3] UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA
[4] UNIV TEXAS, HLTH SCI CTR, DEPT PERIODONT, SAN ANTONIO, TX 78284 USA
[5] HEBREW UNIV JERUSALEM, HADASSAH FAC DENT MED, IL-91010 JERUSALEM, ISRAEL
关键词
D O I
10.1002/(SICI)1097-4652(199609)168:3<570::AID-JCP9>3.3.CO;2-S
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Matrix metalloproteinases (MMPs) are a group of enzymes with the potential to degrade extracellular matrix proteins. One of the MMPs, stromelysin-1 (MMP-3) has been localized to extracellular matrix vesicles in growth plate chondrocyte cultures, suggesting involvement of this enzyme in remodeling of the extracellular matrix during endochondral development, a process which is regulated by the vitamin D metabolites, 1,25-(OH)(2)D-3 and 24,25-(OH)(2)D-3. To determine whether stromelysin-1 is regulated by vitamin D as well, confluent cultures of cells derived from growth zone (GC) and resting zone (RC) rat costochondral cartilage were treated with 1 alpha,25-(OH)(2)D-3 (1,25) and 24R,25-(OH)(2)D-3 (24,25), respectively, and the effect on stromelysin-1 assessed by casein gel zymography and Western blots. Although stromelysin-1 activity was enriched in the matrix vesicle fraction, only the plasma membrane enzyme was affected by the treatment; 1,25 and 24,25 caused a marked decrease in plasma membrane stromelysin-1 activity in their target cells. Since plasma-membrane protein kinase C (PKC) activity is stimulated by 1,25 and 24,25, we hypothesized that stromelysin-1 activity was regulated by the vitamin D metabolites via PKC-dependent phosphorylation. To test this, membrane fractions (containing endogenous PKC alpha and zeta as well as stromelysin-1) were incubated in the presence of purified rat brain PKC and/or recombinant human (rh) stromelysin-1 and [gamma(32)P]-ATP and anti-stromelysin-1 immunoprecipitates were analyzed by autoradiography and Western blots. Immuno-phospho-stromelysin-1 was localized to a 52-kDa band in the plasma membrane fraction only; no phosphorylation was observed in the matrix vesicle fraction. Selective inhibitors of PKC activity demonstrated that phosphorylation was inhibited by H7 and low concentrations of H8, but not by HA1004, indicating that PKC, not PKA, was responsible. Protein phosphatase 2A(1) (PP2A), a serine/threonine-specific phosphatase, selectively removed the radiolabel in a time-dependent manner, providing further support for a PKC-dependent phosphorylation mechanism. Incubation of resting zone cell plasma membranes with 24,25, but not 1,25, resulted in phosphorylation of stromelysin-1, demonstrating that the nongenomic effect was metabolite-specific. This suggests that this may be one mechanism by which vitamin D metabolites regulate stromelysin-1 activity and that PKC-dependent phosphorylation inhibits the metalloproteinase. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:570 / 579
页数:10
相关论文
共 50 条
  • [31] Effect of chondroitin sulfate and hyaluronic acid (500-730 kDa) on synthesis of stromelysin (MMP-3) and MMP-1 in human chondrocyte cultures
    Monfort, J.
    Nacher, M.
    Montell, E.
    Tomas, E.
    Verges, J.
    Benito, P.
    REUMATOLOGIA CLINICA, 2005, 1 (03): : 150 - 154
  • [32] Requirement for protein kinase CK2 but not DNA-dependent protein kinase (DNA-PK) and phosphoinositide 3-kinase (PI3K) activity in modulation of UVB-mediated increase in Collagenase/MMP-1 and stromelysin-1/MMP-3 protein levels in human dermal fibroblasts
    Brenneisen, P
    Wlaschek, M
    Meewes, C
    Schwamborn, E
    Krieg, T
    Scharffetter-Kochanek, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 574 - 574
  • [33] Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines
    Mercapide, J
    De Cicco, RL
    Castresana, JS
    Klein-Szanto, AJP
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (05) : 676 - 682
  • [34] MMP-3 (stromelysin-1) expression is variable in both tumor and stromal cells in malignant pleural mesothetioma (MPM)
    Scott, K
    Rankin, C
    Borden, E
    McKinney, L
    Dexter, E
    Benson, K
    Bowden, GT
    Nagte, R
    Garland, L
    LUNG CANCER, 2004, 46 : S85 - S86
  • [35] Stromelysin-1 (MMP-3) is associated with all cause mortality and heart failure post acute myocardial infarction
    Kelly, D.
    Cockerill, G.
    Ng, L.
    Thompson, M.
    Samani, N.
    Squire, I.
    EUROPEAN HEART JOURNAL, 2007, 28 : 785 - 785
  • [36] The constituent tryptophans and bisANS as fluorescent probes of the active site and of a secondary binding site of stromelysin-1 (MMP-3)
    Dennis E. Epps
    Roger A. Poorman
    Gary L. Petzold
    Christopher W. Stuchly
    Alice L. Laborde
    John H. Van Drie
    Journal of Protein Chemistry, 1998, 17 : 699 - 712
  • [37] Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT)
    Blavier, Laurence
    Lazaryev, Alisa
    Shi, Xiang-He
    Dorey, Frederick J.
    Shackleford, Gregory M.
    DeClerck, Yves A.
    CANCER BIOLOGY & THERAPY, 2010, 10 (02) : 198 - 208
  • [38] The stromelysin-1 (MMP-3) gene and risk of coronary artery disease: a candidate gene that has won the election?
    Humphries, SE
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (01) : 3 - 6
  • [39] Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice
    Suzuki, Y.
    Nagai, N.
    Umemura, K.
    Collen, D.
    Lijnen, H. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) : 1732 - 1739
  • [40] Distinct roles of extracellular signal-regulated kinase and p38 mitogen activated protein kinase in enhancement of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) expression in dermal fibroblasts
    Reunanen, N
    Ahonen, M
    Foschi, M
    Han, J
    Kahari, VM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 439 - 439